JP2003504064A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2003504064A5 JP2003504064A5 JP2001509524A JP2001509524A JP2003504064A5 JP 2003504064 A5 JP2003504064 A5 JP 2003504064A5 JP 2001509524 A JP2001509524 A JP 2001509524A JP 2001509524 A JP2001509524 A JP 2001509524A JP 2003504064 A5 JP2003504064 A5 JP 2003504064A5
- Authority
- JP
- Japan
- Prior art keywords
- piv
- antigenome
- chimeric
- genome
- heterologous
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US14313499P | 1999-07-09 | 1999-07-09 | |
| US60/143,134 | 1999-07-09 | ||
| PCT/US2000/017066 WO2001004320A1 (en) | 1999-07-09 | 2000-06-16 | Attenuated human-bovine chimeric parainfluenza virus (piv) vaccines |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2003504064A JP2003504064A (ja) | 2003-02-04 |
| JP2003504064A5 true JP2003504064A5 (https=) | 2007-06-07 |
| JP4813711B2 JP4813711B2 (ja) | 2011-11-09 |
Family
ID=22502741
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2001509524A Expired - Fee Related JP4813711B2 (ja) | 1999-07-09 | 2000-06-16 | 弱毒ヒト−ウシキメラ−パラインフルエンザウイルス（ｐｉｖ）ワクチン |
Country Status (12)
| Country | Link |
|---|---|
| EP (3) | EP1194564B1 (https=) |
| JP (1) | JP4813711B2 (https=) |
| KR (1) | KR100940776B1 (https=) |
| CN (2) | CN101392239A (https=) |
| AT (1) | ATE408693T1 (https=) |
| BR (1) | BR0013190A (https=) |
| CA (1) | CA2378661A1 (https=) |
| DE (1) | DE60040289D1 (https=) |
| ES (1) | ES2312347T3 (https=) |
| IL (2) | IL147167A0 (https=) |
| MX (1) | MXPA01013302A (https=) |
| WO (1) | WO2001004320A1 (https=) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7192593B2 (en) | 1997-05-23 | 2007-03-20 | The United States Of America, Represented By The Secretary, Department Of Health And Human Services | Use of recombinant parainfluenza viruses (PIVs) as vectors to protect against infection and disease caused by PIV and other human pathogens |
| AU785148B2 (en) * | 1999-12-10 | 2006-10-05 | Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The | Use of recombinant parainfluenza viruses (PIVs) as vectors to protect against infection and disease caused by PIV and other human pathogens |
| US6764685B1 (en) | 2000-03-21 | 2004-07-20 | Medimmune Vaccines, Inc. | Recombinant parainfluenza virus expression systems and vaccines |
| AU2001271909A1 (en) * | 2000-07-05 | 2002-01-14 | The Government Of The United States Of America, As Represented By The Department Of Health And Human Services | Attenuated human-bovine chimeric parainfluenza virus (piv) vaccines |
| CA2435180C (en) | 2001-01-19 | 2019-04-09 | Vironovative B.V. | A virus causing respiratory tract illness in susceptible mammals |
| US8715922B2 (en) | 2001-01-19 | 2014-05-06 | ViroNovative | Virus causing respiratory tract illness in susceptible mammals |
| ATE509097T1 (de) | 2001-11-21 | 2011-05-15 | Us Health | Gewinnung von rekombinantem menschlichem parainfluenzavirus typ 1 (hpivi) aus cdna |
| CN1646684B (zh) | 2002-02-21 | 2010-10-06 | 免疫医疗疫苗公司 | 重组副流感病毒表达系统以及包含源自间质肺病毒的异种抗原的疫苗 |
| WO2004027037A2 (en) | 2002-09-18 | 2004-04-01 | The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services | RECOVERY OF RECOMBINANT HUMAN PARAINFLUENZA VIRUS TYPE 2 (HPIV2) FROM cDNA AND USE OF RECOMBINANT HPIV2 IN IMMUNOGENIC COMPOSITIONS AND AS VECTORS TO ELICIT IMMUNE RESPONSES AGAINST PIV AND OTHER HUMAN PATHOGENS |
| JP2007524372A (ja) | 2003-02-28 | 2007-08-30 | ザ ガバメント オブ ザ ユナイテッド ステイツ オブ アメリカ アズ リプレゼンテッド バイ ザ セクレタリー オブ ザ デパートメント オブ ヘルス アンド ヒューマン サービシーズ | 組換えヒトメタニューモウイルスおよびその使用 |
| CN101410519B (zh) | 2003-04-25 | 2013-04-24 | 免疫医疗有限责任公司 | 间质肺病毒株及其在疫苗制剂中以及用作抗原性序列表达载体的用途和繁殖病毒的方法 |
| WO2005027825A2 (en) * | 2003-04-25 | 2005-03-31 | Medimmune Vaccines, Inc. | Recombinant parainfluenza virus expression systems and vaccines comprising heterologous antigens derived from metapneumovirus |
| CN1871355B (zh) | 2003-06-09 | 2011-12-14 | 惠氏 | 从cDNA中回收非节段性负链RNA病毒的改进方法 |
| CN107818197B (zh) * | 2017-09-15 | 2021-05-25 | 南京航空航天大学 | 一种基于piv技术的超声速翼型的测力方法和装置 |
| GB201816873D0 (en) * | 2018-10-17 | 2018-11-28 | Imperial Innovations Ltd | Fusion protein |
| CN113322241B (zh) * | 2021-05-14 | 2023-06-13 | 金宇保灵生物药品有限公司 | 一种牛副流感病毒3型病毒株bpiv3-nm及其应用 |
| CN116676275B (zh) * | 2023-03-17 | 2024-06-07 | 北京赛尔富森生物科技有限公司 | A基因型嵌合腮腺炎病毒株和制备方法及用途 |
| TW202535439A (zh) | 2023-11-17 | 2025-09-16 | 美商賽諾菲巴斯德公司 | 海藻糖疫苗調配物 |
| CN118909958B (zh) * | 2024-07-25 | 2025-02-07 | 中国兽医药品监察所 | 一株牛副流感病毒3型np蛋白杂交瘤细胞株及单抗和在检测抗原中的应用 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4683195A (en) | 1986-01-30 | 1987-07-28 | Cetus Corporation | Process for amplifying, detecting, and/or-cloning nucleic acid sequences |
| US4683202A (en) | 1985-03-28 | 1987-07-28 | Cetus Corporation | Process for amplifying nucleic acid sequences |
| GB9200117D0 (en) * | 1992-01-06 | 1992-02-26 | Connaught Lab | Production of recombinant chimeric proteins for vaccine use |
| ATE181112T1 (de) | 1995-08-09 | 1999-06-15 | Schweiz Serum & Impfinst | Dem genom von minussträngigen rna-viren entsprechende cdna und verfahren zur herstellung von infektiösen minussträngigen rna-viren |
| AU712213B2 (en) * | 1995-09-22 | 1999-11-04 | Connaught Laboratories Limited | Parainfluenza virus glycoproteins and vaccines |
| US5869036A (en) * | 1995-12-08 | 1999-02-09 | St. Louis University | Live attenuated vaccines based on CP45 HPIV-3 strain and method to ensure attenuation in such vaccine |
| EP0912724B1 (en) | 1996-07-15 | 2009-12-09 | The Government of The United States of America, as represented by The Department of Health and Human Services | Production of attenuated respiratory syncytial virus vaccines from cloned nucleotide sequences |
| KR100702523B1 (ko) * | 1997-05-23 | 2007-04-04 | 더 가번먼트 오브 더 유나이티드 스테이츠 오브 아메리카, 에즈 레프리젠티드 바이 더 디파트먼트 오브 헬쓰 앤드 휴먼 서비시즈 | 클로닝된 뉴클레오타이드 서열로부터 약독화된파라인플루엔자 바이러스를 제조하는 방법 |
-
2000
- 2000-06-15 CN CNA2008100985262A patent/CN101392239A/zh active Pending
- 2000-06-15 CA CA002378661A patent/CA2378661A1/en not_active Abandoned
- 2000-06-15 KR KR1020027000325A patent/KR100940776B1/ko not_active Expired - Fee Related
- 2000-06-16 IL IL14716700A patent/IL147167A0/xx unknown
- 2000-06-16 DE DE60040289T patent/DE60040289D1/de not_active Expired - Lifetime
- 2000-06-16 EP EP00941614A patent/EP1194564B1/en not_active Expired - Lifetime
- 2000-06-16 BR BR0013190-3A patent/BR0013190A/pt not_active Application Discontinuation
- 2000-06-16 CN CNB008101205A patent/CN100402651C/zh not_active Expired - Fee Related
- 2000-06-16 EP EP08164459A patent/EP2019140A3/en not_active Withdrawn
- 2000-06-16 EP EP08164460A patent/EP2019141A3/en not_active Withdrawn
- 2000-06-16 ES ES00941614T patent/ES2312347T3/es not_active Expired - Lifetime
- 2000-06-16 MX MXPA01013302A patent/MXPA01013302A/es active IP Right Grant
- 2000-06-16 WO PCT/US2000/017066 patent/WO2001004320A1/en not_active Ceased
- 2000-06-16 AT AT00941614T patent/ATE408693T1/de not_active IP Right Cessation
- 2000-06-16 JP JP2001509524A patent/JP4813711B2/ja not_active Expired - Fee Related
-
2001
- 2001-12-18 IL IL147167A patent/IL147167A/en not_active IP Right Cessation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2003504064A5 (https=) | ||
| US11801297B2 (en) | Vaccine against RSV | |
| KR100702523B1 (ko) | 클로닝된 뉴클레오타이드 서열로부터 약독화된파라인플루엔자 바이러스를 제조하는 방법 | |
| JP5779226B2 (ja) | 水疱性口内炎ウイルスの相乗的弱毒化、そのベクター及びその免疫原性組成物 | |
| JP4608210B2 (ja) | キメラアルファウイルスレプリコン粒子 | |
| US11028409B2 (en) | Replication-deficient RNA viruses as vaccines | |
| JP4795597B2 (ja) | パラインフルエンザウィルス（ｐｉｖ）及びヒトの病原体により引き起こされる感染及び疾病を保護するためへの組換えｐｉｖのベクターとしての使用 | |
| JP2003516148A5 (https=) | ||
| CA2378497A1 (en) | Recombinant parainfluenza virus vaccines attenuated by deletion or ablation of a non-essential gene | |
| KR20200053518A (ko) | Rsv에 대한 면역의 안전한 유도를 위한 방법 | |
| CN104918952A (zh) | 表达屈曲病毒多肽的重组麻疹病毒及其应用 | |
| JP4813711B2 (ja) | 弱毒ヒト−ウシキメラ−パラインフルエンザウイルス（ｐｉｖ）ワクチン | |
| JP2004515218A5 (https=) | ||
| EP3865180A1 (en) | Live recombinant measles virus expressing coronavirus antigens - its use in eliciting immunity against coronaviruses | |
| US7314631B1 (en) | Use of recombinant live-attenuated parainfluenza virus (PIV) as a vector to protect against disease caused by PIV and respiratory syncytial virus (RSV) | |
| US20100330120A1 (en) | Human parainfluenza viruses having separated p and c genes | |
| HK1118297B (en) | Replication-deficient rna viruses as vaccines | |
| NZ785676A (en) | Vaccine against rsv | |
| OA18878A (en) | Vaccine against RSV | |
| HK1211951B (zh) | 表达屈曲病毒多肽的重组麻疹病毒及其应用 |